Cover Image

Helicobacter pylori EN PACIENTES CON PÚRPURATROMBOCITOPÉNICA INMUNE.

Objective: To study the relationship between H. pylori and ITP. Methods: Descriptive study, longitudinal type and retrospective. Study sample comprised 92 patients with ITP Hematology Service of the University Hospital of Caracas evaluated from July 2005 to July 2015. Results: H. pylori serology was...

Full description

Saved in:
Published: 2017
Subjects:
Helicobacter pylori
contaje plaquetario
erradicación
púrpura trombocitopénica inmune
Immune thrombocytopenic purpura
eradication
platelet count
Online Access:http://hdl.handle.net/10872/15496
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1870622012131508224
bitstream.checksum.fl_str_mv f57a9359af457e0404cabe25e589fa51
7c020282d630887ba819753d2e4a4c58
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
bitstream.url.fl_str_mv https://saber.ucv.ve/jspui/bitstream/10872/15496/1/T026800016672-0-TEG-000.pdf
https://saber.ucv.ve/jspui/bitstream/10872/15496/2/license.txt
dc.contributor.author.none.fl_str_mv Astudillo Nuñez, Heira De Los Ángeles
Sierra Romero, Yvy Milagros
dc.creator.fl_str_mv Astudillo Nuñez, Heira De Los Ángeles
Sierra Romero, Yvy Milagros
dc.date.accessioned.none.fl_str_mv 2017-03-28T19:30:16Z
dc.date.available.none.fl_str_mv 2017-03-28T19:30:16Z
dc.date.issued.none.fl_str_mv 2017
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/10872/15496
dc.language.iso.en_US.fl_str_mv es
dc.publisher.en_US.fl_str_mv UCV
dc.relation.ispartofseries.none.fl_str_mv 2017;1024-001
2017;1024-002
dc.subject.en_US.fl_str_mv Helicobacter pylori
contaje plaquetario
erradicación
púrpura trombocitopénica inmune
Helicobacter pylori
Immune thrombocytopenic purpura
eradication
platelet count
dc.title.alternative.en_US.fl_str_mv Helicobacter pylori IN PATIENTS WITH IMMUNE THROMBOCYTOPENIC PURPURA.
dc.title.en_US.fl_str_mv Helicobacter pylori EN PACIENTES CON PÚRPURATROMBOCITOPÉNICA INMUNE.
dc.type.en_US.fl_str_mv Thesis
description Objective: To study the relationship between H. pylori and ITP. Methods: Descriptive study, longitudinal type and retrospective. Study sample comprised 92 patients with ITP Hematology Service of the University Hospital of Caracas evaluated from July 2005 to July 2015. Results: H. pylori serology was performed in only 14.13% of patients in the sample study, of which 61.54% were positive; 53.85% were female and 7.69% male. ITP pediatric population was most affected by H. pylori (38.46%). Grade 2 bleeding was the most common in patients with positive serology (4.35%) clinical manifestation. Patients who received standard treatment for ITP in conjunction with therapy H. pylori eradication, 46.15% obtained complete response, while 15.39% did not receive eradication therapy achieved a partial response. Conclusions: Studies to determine the presence of H. pylori is not performed routinely in our service although H. pylori infection is one of the most common causes for ITP in our population, with a frequency of 61,54%. Eradication therapy has proven beneficial in the clinical course of these patients, low cost and low side effect profile, so it is important to determine the presence of H. pylori as a causative agent of ITP and initiate eradication treatment one after confirming the infection.
id SABERUCV_b490ad5f2f8ff615f4e413d5ffe3da5f
language_invalid_str_mv es
network_acronym_str SABERUCV
network_name_str Repositorio Institucional de la Universidad Central de Venezuela
oai_identifier_str oai:saber.ucv.ve:10872/15496
publishDate 2017
publishDateSort 2017
repository.mail.fl_str_mv sfwrussians@gmail.com
repository.name.fl_str_mv Saber UCV
repository_id_str
spelling Astudillo Nuñez, Heira De Los ÁngelesSierra Romero, Yvy Milagros2017-03-28T19:30:16Z2017-03-28T19:30:16Z2017http://hdl.handle.net/10872/15496Objective: To study the relationship between H. pylori and ITP. Methods: Descriptive study, longitudinal type and retrospective. Study sample comprised 92 patients with ITP Hematology Service of the University Hospital of Caracas evaluated from July 2005 to July 2015. Results: H. pylori serology was performed in only 14.13% of patients in the sample study, of which 61.54% were positive; 53.85% were female and 7.69% male. ITP pediatric population was most affected by H. pylori (38.46%). Grade 2 bleeding was the most common in patients with positive serology (4.35%) clinical manifestation. Patients who received standard treatment for ITP in conjunction with therapy H. pylori eradication, 46.15% obtained complete response, while 15.39% did not receive eradication therapy achieved a partial response. Conclusions: Studies to determine the presence of H. pylori is not performed routinely in our service although H. pylori infection is one of the most common causes for ITP in our population, with a frequency of 61,54%. Eradication therapy has proven beneficial in the clinical course of these patients, low cost and low side effect profile, so it is important to determine the presence of H. pylori as a causative agent of ITP and initiate eradication treatment one after confirming the infection.Objetivo: Estudiar la relación entre H. pylori y PTI. Métodos: Investigación descriptiva, tipo longitudinal, retrospectiva. Muestra del estudio conformada por 92 pacientes con PTI del Servicio de Hematología del Hospital Universitario de Caracas evaluados entre julio 2005 a julio 2015. Resultados: La serología para H. pylori fue realizada en solo el 14,13% de los pacientes de la muestra en estudio, de los cuales 61,54% resultaron positivos; 53,85% pertenecían al sexo femenino y 7,69% al sexo masculino. La población pediátrica con PTI fue la más afectada por H. pylori (38,46%). Sangrado grado 2 fue la manifestación clínica más frecuente en los pacientes con serologías positivas (4,35%). De los pacientes que recibieron tratamiento estándar para PTI en conjunto con terapia de erradicación de H. pylori, el 46,15% obtuvo respuesta completa y sostenida, mientras que el 15,39% no recibió terapia de erradicación alcanzando una respuesta parcial. Conclusiones: Los estudios para determinar la presencia de H. pylori no se realizan de rutina en nuestro servicio a pesar de que la infección por H. pylori es una de las causas más frecuentes para PTI en nuestra población, con una frecuencia de 61,54%. La terapia de erradicación ha demostrado ser beneficioso en la evolución clínica de estos pacientes, aunado a su bajo costo y bajo perfil de efectos adversos, por ello es importante determinar la presencia de H. pylori como agente causal de PTI e iniciar tratamiento de erradicación una vez confirmada la infección.esUCV2017;1024-0012017;1024-002Helicobacter pyloricontaje plaquetarioerradicaciónpúrpura trombocitopénica inmuneHelicobacter pyloriImmune thrombocytopenic purpuraeradicationplatelet countHelicobacter pylori EN PACIENTES CON PÚRPURATROMBOCITOPÉNICA INMUNE.Helicobacter pylori IN PATIENTS WITH IMMUNE THROMBOCYTOPENIC PURPURA.ThesisORIGINALT026800016672-0-TEG-000.pdfT026800016672-0-TEG-000.pdfapplication/pdf529456https://saber.ucv.ve/jspui/bitstream/10872/15496/1/T026800016672-0-TEG-000.pdff57a9359af457e0404cabe25e589fa51MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-81509https://saber.ucv.ve/jspui/bitstream/10872/15496/2/license.txt7c020282d630887ba819753d2e4a4c58MD5210872/15496oai:saber.ucv.ve:10872/154962017-03-28 19:30:16.211Saber UCVsfwrussians@gmail.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
spellingShingle Helicobacter pylori EN PACIENTES CON PÚRPURATROMBOCITOPÉNICA INMUNE.
Helicobacter pylori
contaje plaquetario
erradicación
púrpura trombocitopénica inmune
Helicobacter pylori
Immune thrombocytopenic purpura
eradication
platelet count
title Helicobacter pylori EN PACIENTES CON PÚRPURATROMBOCITOPÉNICA INMUNE.
title_full Helicobacter pylori EN PACIENTES CON PÚRPURATROMBOCITOPÉNICA INMUNE.
title_fullStr Helicobacter pylori EN PACIENTES CON PÚRPURATROMBOCITOPÉNICA INMUNE.
title_full_unstemmed Helicobacter pylori EN PACIENTES CON PÚRPURATROMBOCITOPÉNICA INMUNE.
title_short Helicobacter pylori EN PACIENTES CON PÚRPURATROMBOCITOPÉNICA INMUNE.
title_sort Helicobacter pylori EN PACIENTES CON PÚRPURATROMBOCITOPÉNICA INMUNE.
topic Helicobacter pylori
contaje plaquetario
erradicación
púrpura trombocitopénica inmune
Helicobacter pylori
Immune thrombocytopenic purpura
eradication
platelet count
url http://hdl.handle.net/10872/15496

Similar Items